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Abstract: Childhood obesity, and specifically its metabolic complications, are related to deficient
antioxidant capacity and oxidative stress. Erythrocytes are constantly exposed to multiple sources
of oxidative stress; hence, they are equipped with powerful antioxidant mechanisms requiring
permanent reducing power generation and turnover. Glucose-6-phosphate dehydrogenase (G6PDH)
and 6-phosphogluconate dehydrogenase (6PGDH) are two key enzymes on the pentose phosphate
pathway. Both enzymes supply reducing power by generating NADPH, which is essential for
maintaining the redox balance within the cell and the activity of other antioxidant enzymes. We
hypothesized that obese children with insulin resistance would exhibit blunted G6PDH and 6PGDH
activities, contributing to their erythrocytes’ redox status imbalances. We studied 15 control and
24 obese prepubertal children, 12 of whom were insulin-resistant according to an oral glucose
tolerance test (OGTT). We analyzed erythroid malondialdehyde (MDA) and carbonyl group levels
as oxidative stress markers. NADP+/NADPH and GSH/GSSG were measured to determine redox
status, and NADPH production by both G6PDH and 6PGDH was assayed spectrophotometrically
to characterize pentose phosphate pathway activity. Finally, superoxide dismutase (SOD), catalase
(CAT), glutathione peroxidase (GPX) and glutathione reductase (GR) activities were also assessed.
As expected, MDA and carbonyl groups levels were higher at baseline and along the OGTT in
insulin-resistant children. Both redox indicators showed an imbalance in favor of the oxidized forms
along the OGTT in the insulin-resistant obese group. Additionally, the NADPH synthesis, as well
as GR activity, were decreased. H2O2 removing enzyme activities were depleted at baseline in both
obese groups, although after sugar intake only metabolically healthy obese participants were able
to maintain their catalase activity. No change was detected in SOD activity between groups. Our
results show that obese children with insulin resistance present higher levels of oxidative damage,
blunted capacity to generate reducing power, and hampered function of key NADPH-dependent
antioxidant enzymes.
Keywords: antioxidants; childhood obesity; insulin resistance; oxidative stress; pentose phosphate
pathway; reducing power
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1. Introduction
Worldwide, more than 300 million children and teenagers between the ages of 5 and
19 years and 41 million children under the age of 5 were overweight or obese in 2016
according to the WHO’s reports [1,2]. Obesity is defined as excessive adiposity caused
by energetic imbalance. Excessive fat accumulation is related to chronic inflammation.
Multiple factors contribute to this relation—innate immune response activation, changes in
cytokines secretion (IL-6, TNF-a, MCP-1, adiponectin and leptin), tissue oxygen depletion,
cell necrosis, and lipid metabolism dysregulation have all been implicated [3,4]. Proinflam-
matory events are elicited in a context of oxidative stress due to reactive oxygen species
(ROS) overproduction. Oxidative stress plays a physiological role by inducing adaptive
responses (phenomenon known as oxidative eustress), but it may also lead to damage
(oxidative distress) [5]. Accordingly, lipid peroxidation products may trigger both cellular
adaptive responses and cytotoxicity [6]. Cell tolerance to oxidative stress is primarily
enhanced through induction of antioxidant enzymes which may be compromised as the
disease evolves, switching from a eustress to a distress situation [7]. Oxidative stress plays
a pivotal role in the development of a wide variety of diseases, such as diabetes, certain
types of cancers, as well as neurodegenerative and cardiovascular diseases [8–12].
Erythrocytes are very particular cells. They are ubiquitous, have a relatively high
turnover rate, lack nuclei, mitochondria and other organelles, and are extremely specialized.
Due to their main function as oxygen transporters and their high iron content, erythrocytes
are highly exposed to reactive oxygen/nitrogen species (ROS/RNS), and also to external
inputs such as advanced glycation/lipoxidation end products (AGEs/ALEs) [13–15]. Thus,
they are equipped with powerful antioxidant systems which may be classified into en-
zymatic (catalase, superoxide dismutase, thioredoxin, etc.) and nonenzymatic defenses
(ascorbic acid, glutathione, etc.) responsible for controlling redox balance [16–18]. This
makes erythrocytes reflect variations in oxidative status very early and have been pro-
posed as sensors of oxidative stress [16]. In fact, a group of obese children with metabolic
complications (insulin resistance, IR) presented antioxidant response depletion and en-
hanced oxidative stress markers in response to an oral glucose tolerance test (OGTT), while
metabolically healthy obese children were able to effectively increase their antioxidants de-
fenses to avoid oxidative damage [16]. Some of the above-mentioned antioxidant defenses
need to be supplied with reducing power to exert their function. Glutathione, for example,
needs to be recycled (when oxidized) by glutathione reductase, an NADPH-dependent
enzyme, and catalase is also NADPH-dependent to avoid inactivation [19]. Moreover,
NADPH oxidase or inducible nitric oxide synthase (eNOS) activities are dependent on
NADPH in the erythrocyte [20].
Under physiological conditions, most of the glucose consumed by the erythrocyte is
derived from the production of energy by glycolytic activities. Only a small fraction is used
in the pentose phosphate pathway (PPP) to provide reducing power in the erythrocyte. In
the PPP, glucose-6-phosohate dehydrogenase (G6PDH) and 6-phosphogluconate dehydro-
genase (6PGDH) catalyze the reduction of NADP+ to NADPH, renewing its antioxidant
power. To this end, they use the energy resulting from glucose-6-phosphate conversion to
6-phosphogluconolactone and 6-phosphogluconate to ribulose-5-phosphate, respectively.
Under oxidative stress, this cycle must be upregulated to increase its activity, which can be
as much as 20-fold. In this sense, the first enzyme in the pathway (G6PDH) plays a pivotal
role in its regulation, since its activity is controlled by the NADP+/NADPH ratio [21,22].
The potential role of PPP dysregulation in the oxidative damage associated with obesity
and its comorbidities remains unexplored.
In this work, we aim to assess the potential role of the PPP by analyzing the activity
of the main NADP dehydrogenases and their ability to provide reducing power in the
erythrocytes of obese children with insulin resistance (ObIR+) as compared to a group of
metabolically healthy obese (ObIR−) participants and a group of healthy controls. Our data
confirm the presence of an oxidative environment in a population of prepuberal ObIR+
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children, and evidence in these a dysregulated PPP activation, resulting in a deficient
response to a glucose overload as compared with the other study groups.
2. Material and Methods
2.1. Subjects
Obese children requiring an OGTT to assess their carbohydrate metabolism were
recruited at our Pediatric Endocrinology Unit (n = 24) in Puerta del Mar University Hospital,
Cádiz, Spain. Nonobese children who needed a blood test (generally for preanesthesia),
were recruited as control group (n = 15). All of them were prepubertal children, between 6
and 10 years of age.
Inclusion criteria for the obese group were children between 6 and 10 years in a tanner
stage I with a BMI > +2 SD and, as mentioned above, with a medical prescription of an
OGTT. On the other hand, the control group had a BMI < +2 SD and, as the obese group, an
age between 6 and 10 years and Tanner I. We subdivided the obese group according to the
result of the OGTT and their basal glucose and insulin levels. Patients were classified into
the ObIR− group when they showed no evidence of carbohydrate metabolic impairment
and into the ObIR+ group when presenting at least one of the following criteria: Impaired
fasting glucose (IFG), impaired glucose tolerance (IGT) or insulin resistance (IR), according
to the ADA criteria (a homeostasis model assessment of insulin resistance (HOMA-IR)
score above 3.5, or fasting insulin > 15 µUI/mL, insulin at 120 min of OGTT > 75 µUI/mL
or insulin at any time point of the curve > 150 µUI/mL [23]). Every OGTT was performed
by a trained nurse in the clinic, after overnight fasting, with 1.75 g/kg (maximum 75 g) of
sucrose (GlycoSull, QCA S.A., Tarragona, Spain). The control group was not subjected to
the OGTT.
2.2. Sample Collection and Preparation
Venous blood samples were extracted in serum (gelose) and plasma (EDTA) separating
tubes from every child after overnight fast (T0). For obese children, blood samples were
also collected at 60 and 120 min during the OGTT. Every tube was processed as previously
described [9]. Both blood collection tubes were centrifuged at 1500× g for 10 min at 4 ◦C
to obtain serum and plasma samples. Plasma-separating tubes were also used for the
immediate purification of red blood cells (RBCs) for determination of oxidative stress and
antioxidant biomarkers. Briefly, erythrocytes were washed 3 times with 5 mL of cold saline
solution (NaCl 9 g/L) to obtain the RBC fraction by centrifuging for 5 min at 1500× g and
4 ◦C. In total, 300 µL of this RBC solution was lysated by hypotonic shock with 4 mL of
distilled water, and then subjected to centrifugation at 17,000× g for 10 min at 4 ◦C to
separate membranes (pellet) and cytosol (supernatant). The pellet was resuspended in
RIPA buffer, while the cytosolic fraction was treated with 750 µL Chloroform:Ethanol (1:2;
v/v) to remove hemoglobin. To obtain hemoglobin-free cytosolic fractions, samples were
centrifuged again at 1500× g for 10 min at 4 ◦C. Every fraction was immediately frozen in
liquid nitrogen to ensure its correct preservation.
2.3. Anthropometry and Biochemical Analysis of the Study Population
Demographic data, personal and familiar cardiovascular antecedents, and risk factors
were collected from the electronic medical records. Anthropometric data were measured and
puberal findings were evaluated by pediatric endocrinologists. Z-scores for age and gender
for every anthropometric variable were also registered using Spanish reference values.
Biochemical analysis included insulin and glucose determination at basal and at
different times along the OGTT. The homeostasis model assessment of insulin resistance
(HOMA-IR) was also calculated by applying the formula: HOMA-IR = [(fasting insulin
(mIU/L) × fasting glucose (mg/dL) × 0.055/22.5]. Biochemical analysis was performed
on serum by using standard clinical assays at the Clinical Analysis Department of our
Hospital. Insulin was measured in a Roche Analytics E170 analyzer using the “INSULIN
100 TESTS/KT” (Roche Diagnostics, Indianapolis, IN, USA) (imprecision insulin assay was
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2.26%), and serum glucose was analyzed by the hexokinase method in a C8000 analyzer
(Roche Diagnostics, Indianapolis, IN, USA) (imprecision glucose assay was 2% at standard
level (100 mg/dL) and 3% at top level (240 mg/dL)).
2.4. Lipid Peroxidation Quantification
The formation of thiobarbituric acid-reacting substances (TBARS) was measured
according to the method described by Buege et al. [24]. In total, 100 µL of diluted RBC
samples (1:1, v/v; in water) was mixed with 400 µL of the reaction solution, composed
by 2.5 N HCl, 0.375% (w/v) thiobarbituric acid (TBA), 15% (w/v) trichloroacetic acid, and
0.01% (w/v) butylated hidroxytholuene. Then, for lipid fraction purification and incubation
with TBA, the mix was heated at 100 ◦C for 15 min and, after cooling, centrifuged at 900× g
for 5 min. The malondialdehyde (MDA) standard curve was prepared in the same way but
without heating and centrifuging. Finally, 200 µL of each sample and MDA curve were
added to a 96-well microplate and the absorbance was recorded at 535 nm. Results were
expressed as nmol of MDA per mg of proteins in RBCs.
2.5. Carbonyl Groups Determination
For quantifying oxidative modification of proteins, carbonyl groups (C = O) were
determined following the method described by Levine et al. [25]. It was based on the
purification of proteins from samples and their incubation with 2,4-dinitrophenylhydrazine
(DNPH) in 6 M HCl-guanidine, which when reacting with the carbonyl groups produce
2,4-phenylhydrazone. In the presence of 10 M KOH, hydrazone can be determined spec-
trophotometrically by its absorbance at 370 nm. Each sample had its own blank (without
DNPH). Differences in absorbance between samples and blanks were employed to quantify
the content of carbonyl groups. Absorbance at 280 nm measured in blanks was used to
estimate the protein content of the samples using a BSA standard curve prepared in 6 M
HCl-guanidine. Results are expressed as nmol of C = O per mg of proteins in RBCs.
2.6. Glutathione Availability
The analysis of RBC glutathione equivalents (tGSH) was performed following the
“DTNB-GSSG Reductase Recycling Assay for GSH and GSSG”, based on the GSH oxidation
to GSSG by the 5,5′-dithiobis-2-nitrobenzoic acid (DTNB) [26]. The product, 5-thio-2-
nitrobenzoic acid (TNB), can be monitored by spectrophotometry at 412 nm. Since GSSG
was reduced to GSH, the sum of GSH and GSSG (tGSH) could be measured when a
highly specific glutathione reductase and NADPH was present in the reaction. GSSG
concentration can be analyzed by the same method if samples are previously derivatized
with Triethanolamine (TEA) and 2-vinylpyridine. Previous to this analysis, samples were
diluted (1:5) in 5% metaphosphoric acid and centrifugated for the elimination of proteins’
sulfhydryl groups. Data were expressed as nmol of GSH/GSSG/tGSH per mg of protein.
Finally, redox status was expressed as GSH/GSSG.
2.7. NADPH Availability
Total NADP (tNADP) and NADPH were quantified in erythrocytes using the commer-
cial kit “NADP/NADPH Assay kit”, following the manufacturer’s instructions (Abcam,
Cambridge CB4 OFL, UK). Briefly, erythrocytes were incubated at 60 ◦C for 30 min to
decompose NADP+. Then, 10 µL of treated and untreated samples were placed in a 96-well
plate for the spectrophotometric determination of NADPH and NADP+ concentrations, re-
spectively, at 450 nm. This technique enables the extrapolation of NADP+ concentration in
order to estimate the NADP+/NADPH ratio as a redox status indicator. Data are expressed
as pmol of NADP+ or NADPH per mg of protein.
2.8. NADP-Dehydrogenase Activities
Both G6PDH (EC:1.1.1.49) and 6PGDH (EC:1.1.1.44) activities were determined spec-
trophotometrically by quantifying the rate of NADP+ reduction as described by Mateos et al., 2009 [27].
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Therefore, 10 µL of sample was mixed in the wells of a microplate with 36.11 mM HEPES
and 0.8 mM NADP+. Finally, substrate (glucose-6-phosphate for G6PDH activity and
6-phosphogluconate for 6PGDH activity) was added to start the reaction. Absorbance
was followed at 340 nm for 3 min with determinations every 20 s. The molar extinction
coefficient for NADP+ was 6.22 mM−1 cm−1. The enzymatic activity was expressed as
nmol NADP min−1 per mg of protein.
2.9. Glutathione Reductase Activity
Glutathione reductase (EC 1.8.1.7) activity was determined by following the NADPH
oxidation rate that the enzyme uses to recycle reduced glutathione (GSH) from oxidized
glutathione (GSSG), as described by Edwards et al. [28]. In total, 0.1 M HEPES-NaOH
buffer pH 7.8 with 1 mM EDTA and 3 mM MgCl2 was added to a 96-well microplate
together with 0.5 mM GSSG (samples) or without it (blanks). Then, 5 µL of sample and
0.2 mM NADPH were added to start the reaction. Absorbance was followed at 340 nm
for 2 min with determinations each 10 s. The molar extinction coefficient for NADPH was
6.22 mM−1 cm−1. The enzymatic activity was expressed as nmol NADP min−1 per mg
of protein.
2.10. Glutathione Peroxidase Activity
Glutathione peroxidase (EC 1.11.1.9) activity was measured spectrophotometrically using
the “Glutathione Peroxidase Assay Kit” (Abcam, Cambridge CB4 OFL, UK), following manufac-
turer’s instructions. Glutathione peroxidase (GPX) catalyzes the reduction of H2O2 to H2O via
GSH oxidation to GSSG. The decrease in NADPH, proportional to GPX activity, was monitored
at 340 nm. The enzymatic activity was expressed as nmol H2O2 min−1 per mg of protein.
2.11. Catalase Activity
Catalase (EC 1.11.1.6) activity was measured following the protocol described by
Aebi et al. [29], based on the absorbance decrease at 240 nm due to the catalase mediated
H2O2 decomposition. Briefly, samples were diluted with distilled water (1:100 v/v), and
2 µL of the diluted samples was added to 50 mM phosphate buffer at pH 7 with 9.96 mM
H2O2. The absorbance was measured at 240 nm. The enzymatic activity was expressed
as nmol H2O2 min−1 per mg of protein, with a molar extinction coefficient for H2O2
of 39.58 M−1 cm−1.
2.12. Superoxide Dismutase Activity
Superoxide dismutase (EC 1.15.1.1) activity was measured in erythrocytes using
the commercial kit “EpiQuik™ Superoxide Dismutase Activity/Inhibition Assay Kit”,
following manufacturer’s instructions (Epigentek, Farmingdale, NY, USA). The principle
of this assay is based in the formation of a colored water-soluble formazan upon reduction
of a dye with superoxide anion. Thus, the higher the superoxide dismutase (SOD) activity
is in the sample, the lower the rate formation of formazan that takes place, resulting in
lower OD values at 470 nm. Data are shown in mU/µL*mg protein.
2.13. Statistical Analysis
The significance tests used were the nonparametric test: the Mann–Whitney U test
for pairwise comparisons, and Kruskal–Wallis test (followed by the Dunn’s test) for com-
parisons of more than two groups. When comparing categorical variables, we applied the
Chi-square statistic. The sample size was calculated using GRANMO 7.12 sample size
calculator open software [30], based on previous data on lipid peroxidation levels [16].
Hence, accepting an alpha risk of 0.05 and a beta risk of 0.2, assuming a common standard
deviation of 0.47, the estimated sample size to recognize as statistically significant a dif-
ference greater or equal to 0.6 units is 10 subjects per group, for the comparisons between
groups. For intragroup comparisons (repeated measurements), and accepting the same
risks in a two-sided test, 8 subjects per group were calculated as necessary to recognize
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statistically significance, which was determined as a difference greater than 0.46, assum-
ing a common standard deviation of 0.5 and a correlation coefficient between initial and
final measurements of 0.8. Eventually, the statistical power of our sample was calculated,
considering the real data of each variable, and obtained a mean power of 81.29%.
3. Results
3.1. Anthropometry and Biochemical Analysis of the Study Population
As shown in Table 1, age was similar in every group. Distribution according to sex
was similar between controls and ObIR−, but in the ObIR+ group there were twice as many
boys than girls. There were no clinically relevant differences between groups in any of the
neonatal variables. ObIR+ had lower mean weight at birth than ObIR−, but all three groups
had mean weights at birth within normal values (between −2 and +2 SD). In addition to
the obvious differences in obesity-related parameters, such as waist circumference and
BMI (SD), between nonobese and obese children, no other differences were found between
ObIR− and ObIR+ anthropometric variables. Similarly, blood pressure was higher in both
obese groups as compared to controls, but there were no differences between obese groups
with or without IR.
Table 1. Anthropometric and biochemical characteristics of the study population.
Control ObIR− ObIR+
Anthropometric parameters
Number of subjects (N) 15 14 10
Sex 8♂7♀ 6 ♂8 ♀ 7♂3 ♀
Age (years) 8.33 ± 0.42 8.79 ± 0.48 8.71 ± 0.44
WC (cm) 55.76 ± 1.57 93.89 ± 5.00 aaaa 92.38 ± 2.18 aaaa
WC (Z-Score) −0.52 ± 0.25 5.20 ± 0.61 aaaa 5.36 ± 0.70 aaaa
Weight (kg) 25.17 ± 1.31 54.80 ± 3.88 aaaa 59.58 ± 3.67 aaaa
Weight (Z-Score) −0.65 ± 0.18 4.28 ± 0.34 aaaa 5.52 ± 0.87 aaaa
Height (cm) 124.25 ± 2.28 138.37 ± 3.15 aa 140.38 ± 2.79 aaa
Height (Z-Score) −1.07 ± 0.17 1.45 ± 0.31 aaaa 3.11 ± 1.65 aaaa
BMI (kg/m2) 16.11± 0.40 27.81 ± 1.20 aaaa 30.16 ± 1.43 aaaa
BMI (Z-Score) −0.48 ± 0.14 4.12 ± 0.31 aaaa 5.02 ± 0.73 aaaa
Gestational age (weeks) 39.23 ± 0.63 39.34 ± 0.63 39.78 ± 0.55
Newborn weight (g) 3199 ± 152.27 3418 ± 130.88 3155 ± 176.15
Newborn weight (Z-Score) −0.04 ± 0.22 0.59 ± 0.32 −0.40 ± 0.27 b
Newborn height (cm) 50.14 ± 1.07 51.15 ± 0.72 50.29 ± 1.08
Newborn height (Z-Score) 0.38 ± 0.36 0.80 ± 0.40 −0.18 ± 0.54
Systolic BP (mmHg) 103.90 ± 3.60 118.09 ± 4.584 a 123.50 ± 4.73 aa
Systolic BP (Z-Score) 0.61 ± 0.32 1.49 ± 0.41 1.97 ± 0.41 a
Diastolic BP (mmHg) 63.10 ± 4.76 75.27 ± 2.65 a 77.88 ± 3.38 a
Diastolic BP (Z-Score) 0.43 ± 0.41 1.28 ± 0.22 a 1.38 ± 0.31 a
Biochemical parameters
Blood glucose curve (mg/dL)
0 min 85.13 ± 1.41 84.57 ± 1.15 90.70 ± 2.87 b
30 min n.d. 118.67 ± 11.46 126.40 ± 15.38
60 min n.d. 114.55 ± 6.08 125.38 ± 11.45
90 min n.d. 110.45 ± 2.89 122.50 ± 7.47
120 min n.d. 108.55 ± 3.84 120.75 ± 8.16
Blood insulin curve (µUI/mL)
0 min 4.84 ± 0.55 11.61 ± 1.05 aaaa 25.29 ± 5.33 aa,b
30 min n.d. 58.65 ± 10.52 208.84 ± 55.78 b
60 min n.d. 79.98 ± 13.32 200.65 ± 31.98 bb
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Table 1. Cont.
Control ObIR− ObIR+
90 min n.d. 60.80 ± 9.15 185.26 ± 23.99 bbbb
120 min n.d. 47.60 ± 6.95 179.79 ± 31.33 bbb
HOMA-IR 1.03 ± 0.13 2.35 ± 0.21 aaaa 6.81 ± 1.36 aaa,bbb
Total Cholesterol (mg/dL) 155.67 ± 11.06 163.85 ± 9.41 154.40 ± 9.26
Triglycerides (mg/dL) 57.60 ± 7.40 92.15 ± 13.80 a 112.50 ± 19.04 aa
HDL-C (mg/dL) 64.93 ± 6.18 45.73± 2.00 aa 41.00 ± 2.96 aaa
LDL-C (mg/dL) 93.00 ± 6.29 98.91 ± 8.67 91.00 ± 6.83
Creatinine (mg/dL) 0.5 ± 0.02 0.54 ± 0.02 0.59 ± 0.03 a
GOT (U/L) 28.92 ± 1.12 23.09 ± 1.38 aa 24.38 ± 2.12
GPT (U/L) 16.92 ± 1.28 21.67 ± 1.24 a 27.90 ± 5.29 a
Ferritin (mg/mL) 29.82 ± 3.01 37.72 ± 6.11 59.34 ± 8.24 aa,b
Values are shown as the mean ± SEM. a indicates difference with respect to control (a p < 0.05, aa p < 0.01, aaa p < 0.001 and aaaa p < 0.0001)
at baseline and b refers to differences relative to obese children without insulin resistance (ObIR−) (b p < 0.05, bb p < 0.01 and bbb p < 0.001,
bbbb p < 0.0001). WC, waist circumference; BMI, body mass index; BP, blood pressure; HOMA-IR, homeostasis model assessment of insulin
resistance; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; GOT, aspartate transaminase; GPT,
alanine transaminase.
As expected by the definition of the study groups, there were significantly higher
insulin levels in the OGTTs and elevated HOMA-IR indexes in the ObIR+ with respect
to control and ObIR− groups. Interestingly, basal insulin and HOMA-IR index was also
higher in the ObIR− group than in controls, although both levels were within the normal
ranges. Glucose levels, however, were similar between controls and ObIR−, whilst ObRI+
had slightly higher basal glucose, still within normal levels. Both obese groups had
similar TGs, and these were approximately double those in the control groups. Total and
LDL-cholesterol values were not different among any group, while HDL-cholesterol was
lower in both obese populations, without differences between ObIR− and ObIR+. Finally,
ferritin levels in the ObIR+ were twice as high as in any other group, and this difference
was statistically significant. Creatinine levels were also higher in ObIR+ groups when
compared to controls.
3.2. Oxidative Damage
MDA levels were analyzed in total RBC samples, whilst carbonyl groups were only
determined in the RBC intracellular fraction. We found baseline levels of MDA to be higher
in the ObIR+ group when compared to the control group. Additionally, MDA values
showed tendency to increase along the OGTT in the ObIR+ group, although no significant
differences were found in any other study point (Figure 1A). Carbonyl groups profile
showed a 5-fold increase in the ObIR+ group with respect to the control group at baseline,
and 2-fold increase over the ObIR− group at 120 min after OGTT (Figure 1B).
3.3. Glutathione Availability
ObIR+ children exhibited an increase in GSSG levels 60 min after the OGTT; in contrast,
only ObIR− experienced changes in GSH values along the curve, reaching the maximum at
the 120 min time point (Figure 2A,B). No changes were found in tGSH levels in both obese
groups along the OGTT (Figure 2C). Finally, GSH/GSSG was disbalanced at baseline in
ObIR+ and it changed after an OGTT in both obese group, resulting in a decrease along the
curve in ObIR+, with significant changes at 120 min, whilst ObIR− increased GSH/GSSG
along the curve (Figure 2D).
3.4. NADPH Availability
Total NADP levels were similar in all three groups at baseline and remained un-
changed along the OGTT in both obese groups (Figure 3A). Levels of NADPH were also
similar in all three groups at baseline and remained in similar values in ObIR− along the
curve, while the ObIR+ group showed a decreasing trend that did not reach statistical sig-
nificance (p = 0.098) (Figure 3B). Conversely, NADP+/NADPH ratio was similar between
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groups at baseline, but markedly increased at 120 min of the OGTT only in the ObIR+ obese
group (Figure 3C).




Figure 1. Levels of oxidative damage in red blood cells (RBCs) of healthy and obese children. 
Malondialdehyde (MDA) (A) and carbonyl group levels (B) were measured in RBCs at baseline 
and along oral glucose tolerance test (OGTT). White bars represent the control group, grey bars 
represent ObIR− group, and black bars represent obese children with insulin resistance (ObIR+) 
group. Values are means ± SEM. p < 0.05 was considered for statistical significance. (a) shows sig-
nificant differences relative to control at baseline and (b) shows significant differences relative to 
ObIR−. 
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ObIR+ children exhibited an increase in GSSG levels 60 min after the OGTT; in con-
trast, only ObIR− experienced changes in GSH values along the curve, reaching the max-
imum at the 120 min time point (Figure 2A,B). No changes were found in tGSH levels in 
both obese groups along the OGTT (Figure 2C). Finally, GSH/GSSG was disbalanced at 
baseline in ObIR+ and it changed after an OGTT in both obese group, resulting in a de-
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Figure 1. Levels of oxidative damage in red blood cells (RBCs) of healthy and obese children.
Malondiald hyde (MDA) (A) and carbonyl gr up levels (B) were measured in RBCs at baseline and
along oral glucose tolerance test (OGTT). White bars represent the control group, grey bars represent
ObIR− group, and black bars represent obese children with insulin resistance (ObIR+) group. Values
are means± SEM. p < 0.05 was considered for statistical significance. (a) shows significant differences
relative to control at baseline and (b) shows significant differences relative to ObIR−.
3.5. NADP-Dehydrogenases Activities
Both G6PDH and 6PGDH activities were quantified in RBCs. The activities of both de-
hydrogenases appeared to be exacerbated at baseline in ObIR+, with significant differences
when compared to controls in G6PDH and to control and ObIR− in 6PGDH. However,
along the curve, both G6PDH and 6PGDH activities suffered a marked decrease in ObIR+.
On the other hand, the ObIR− group decrease their G6PDH activity at 60 min, which was
recovered to basal levels at 120 min (Figure 4A,B).
3.6. Glutathion Reductase Activity
Glutathione reductase (GR) activity, measured in RBC cytoplasm, peaked in ObIR−
at 60 min, while ObIR+ did not experience any change along the curve, with significant
differences between both obese groups 60 and 120 min after the OGTT (Figure 5).
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Figure 2. Glutathione availability in RBCs of healthy and obese children. GSH (A) and GSSG (B) were
measured in RBCs at baseline and along OGTT. tGSH (C) and GSH/GSSG (D) were also calculated.
White bars represent the control group, grey bars represent ObIR− group, and black bars represent
ObIR+ group. Values are means ± SEM. p < 0.05 was considered for statistical significance. (a) shows
significant differences relative to control at baseline, (b) shows significant differences relative to
ObIR−, and (#) shows intragroup differences along the OGTT.
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Figure 3. NADPH availability in RBCs of controls and obese children. Total NADP (tNADP) (A) and
NADPH (B) were measured in RBCs at baseline and along OGTT. NADP+ data were extrapolated
from both total NADP and NADPH and used to calculate the NADP+/NADPH ratio (C). White bars
represent the control group, grey bars represent ObIR− group, and black bars represent ObIR+ group.
Values are means ± SEM. p < 0.05 was considered for statistical significance. (b) shows significant
differences relative to ObIR−, and (#) shows intragroup differences along the OGTT.
3.7. H2O2 Removing Enzymes
Glutathione peroxidase (GPX) and catalase (CAT) activities were decreased at baseline
in both obese groups as compared to controls (Figure 6A,B, respectively), although only
the ObIR+ group reached statistical difference in their catalase activity at this point. GPX
activity did not increase along the curve in neither obese group. Additionally, whilst ObIR+
were unable to increase levels of catalase activity along the curve, ObIR− responded to the
OGTT increasing their catalase activities at 60 min.
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Figure 4. NADP+-dehydrogenase Activity in RBCs of healthy and obese children. Glucose-6-
phosphate dehydrogenase (A) and 6-phosphogluconate dehydrogenase (B) activities were measured
in RBCs at baseli e nd along OGTT. White bars r present the control group, grey ba s r present
ObIR− group, and black bars represent ObIR+ group. V lues are means ± SEM. p < 0.05 was
considered for statistical significance. (a) shows significant differences relative to c ntrol at baseline,
(b) shows significant differences relative to ObIR−, and (#) shows intragroup differences along
the OGTT.
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Figure 5. Glutathione reductase activity in RBCs of healthy and obese children. Glutathione reductase
activity were measured in RBCs at basel e and along OGTT. Whit bars represent the control group,
grey bars represent ObIR− group, and black bars represent ObIR+ group. Values are means ± SEM.
p < 0.05 was considered for statistical significance. (b) shows significant differences relative to ObIR−.
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Figure 6. H2O2 removing enzymes. Glutathione peroxidase (A) and catalase (B) were measured
in RBCs of healthy and obese children at baseline and along OGTT. White bars represent the con-
trol group, grey bars represent ObIR− group, and black bars represent ObIR+ group. Values are
means ± SEM. p < 0.05 was considered for statistical significance. (a) shows significant differences
relative to control at baseline, (b) shows significant differences relative to ObIR−, and (#) shows
intragroup differences along the OGTT with respect to baseline values.
3.8. Superoxide Dismutase Activity
Superoxide dismutase (SOD) activity was similar at baseline and remained unchanged
along the OGTT in every group (Figure 7).
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and black bars represent ObIR+ group. Values are means ± SEM. p < 0.05 was considered for
statistical significance.
A graphic summary of our results is shown in the Supplementary Figure S1.
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4. Discussion
Obesity and childhood obesity have become one of the most relevant diseases from the
end of last century since their prevalence have increased in the past decades at exponential
levels. Their incidence, together with the associated comorbidities and risk of developing
other diseases in the future, make obesity an issue of major importance. Oxidative stress
has been widely related to the pathophysiologies of several disorders and associated with
childhood obesity [16,31]. Since oxidative stress-mediated complications may play a pivotal
role in the development of obesity-related comorbidities a special effort must be made to
assess the biological and molecular bases of this oxidative dysfunction.
In this work, we describe MDA and carbonyl groups to be elevated in ObIR+ children’s
erythrocytes when compared with a control group at baseline and compared to ObIR−
children after an OGTT. These results reproduce previously published data in a cohort
of children between 4 and 14 years [16], reinforcing the evidence of the relation between
metabolic impairment and oxidative stress even at pediatric ages, although in the present
study, this is more specifically before puberty. Elevated concentrations of lipid peroxidation
markers in urine samples of obese children have been described to be predictors of higher
risk of developing cardiovascular diseases [32], while carbonyl groups have also been
related to childhood obesity and metabolic syndrome in several works [33,34].
Erythrocytes are circulating cells exposed to the action of endogenous and exogenous
sources of ROS and, therefore, targets of systemic oxidative stress. ROS generated by other
cells in the circulatory system (endothelial cells, monocytes or neutrophils) may penetrate
into the erythrocyte [35]. Furthermore, endogenously, hemoglobin autoxidation, NADPH
oxidase activity or the Fenton and Haber–Weiss reactions contribute to the generation of
ROS within the erythrocyte, as potential sources of oxidative stress [36]. Therefore, the
availability of reducing power (NADPH) to control glutathione homeostasis in these cells,
as well as the activity of the antioxidant enzymes involved in glutathione metabolism, is
essential to maintain the physiological response of the cell to these potential oxidative
stress sources to which it is exposed.
To estimate the redox status in red blood cells, glutathione and NADPH availability
were assessed. Both redox indicators were imbalanced in favor of the oxidized forms
in those obese children with IR. On the contrary, GSH/GSSG in ObIR− increased in
response to sugar intake. Our previous work also found an altered GSH/GSSG ratio in
ObIR+ children, whilst the ObIR− group was able to increase the amount of GSH over
the oxidized form [16]. These results show how IR induces redox impairments even in
prepuberal children, stressing the importance of controlling metabolic dysregulation from
early ages. In line with these findings, cells with lower GSH levels have been shown to
be more sensitive to oxidative damage [37]. Moreover, altered glutathione homeostasis
has been related to several diseases such as tuberculosis, human immunodeficiency virus
(HIV) infection, diabetes, Parkinson’s disease or cardiovascular diseases [38–40].
Considering the inability of insulin-resistant obese children to correctly recycle the ox-
idized form of the endogenous antioxidant glutathione to its reduced form under stressful
conditions, we evaluated the behavior of the antioxidant enzyme glutathione reductase,
responsible for the reduction of GSSG into GSH, with the consumption of reducing power
in form of NADPH. Although controls and both obese groups had similar glutathione
reductase activity levels at baseline, in response to the OGTT only the metabolically healthy
obese group was able to increase the glutathione reductase activity. This result could
explain, at least in part, the differential dynamics observed in glutathione availability be-
tween groups, since ObIR− effectively increased GSH concentration along the curve, whilst
ObIR+ experienced an increase in GSSG. Glutathione reductase activity has been previously
described to be decreased in childhood obesity and in metabolic syndrome. Moreover,
in an interventional study in a group of obese women, weight loss led to an increase in
glutathione reductase activity [41–43]. On the other hand, some authors found morbidly
obese adults, and adults with metabolic syndrome, to have increased levels of glutathione
reductase activity and even glutathione reductase protein levels [44–46]. To the best of our
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knowledge, the role of insulin resistance in this antioxidant enzyme in obese children has
not yet been looked at to date. Our results establish a link between altered glutathione
reductase activity and the pathophysiology of childhood obesity metabolic complications.
Since glutathione reductase needs NADPH to accomplish the recycling of GSSG into
GSH, any disturbance in the PPP may eventually lead to altered glutathione reductase
activity and thus, inefficient antioxidant defenses. As described above, although ObIR+
children had exacerbated G6PDH and 6PGDH activities at baseline, an acute glucose
intake resulted in a marked decrease in both enzymes’ activities, depriving the erythrocyte
of the necessary reducing power to face the generated stress. Higher baseline levels of
G6PDH and 6PGDH activities may trigger deleterious signaling effects, since the NADPH
generated is a substrate for the superoxide producer NADPH oxidase (NOX). In fact, NOX
and the inducible nitric oxide synthase (iNOS) have been described as playing a key role
in ROS generation in obese adipose tissue that may lead to insulin resistance. Moreover,
upregulated G6PDH levels/activity were observed in many cancer types [47]. In line
with this, erastin-mediated ferroptosis (programmed cell death dependent on iron) was
lowered by NOX/PPP inhibitors and in knockout mice of two PPP enzymes, G6PDH and
6PGDH, suggesting an implication of NOX and some PPP enzymes in this newly described
form of regulated cell death characterized by reduced GSH levels and increased lipid
peroxidation [48]. Thus, NADPH has a dual role in ROS generation. In line with this, RBCs
are highly dependent on G6PDH-derived NADPH to maintain the balance between the
oxidized and reduced forms of glutathione. The lack in erythrocytes of any other reducing
power source, makes them extremely sensitive to oxidative stress under impaired G6PDH
activity conditions [49]. Additionally, in studies of animal models (high fat diet (HFD)
mice), skeletal muscle G6PDH has been shown to be defective under insulin-stimulated
conditions, in line with our results [50]. High glucose concentration-mediated impaired
G6PDH activity has also been related to an increase in ROS production and reduction in
cell survival in endothelial and kidney cells [51].
The decrease in NADPH availability after the OGTT in ObIR+ is related to an impaired
activity of NADPH-dependent enzymes such as glutathione peroxidase and glutathione
reductase. Additionally, catalase remains unable to increase response to OGTT in ObIR+, as
previously described [16]. Although catalase activity does not strictly depend on NADPH,
it has been described that NADPH intervenes in the stabilization of the active form of the
protein [19]. We now reproduce this result in a cohort of prepuberal children, clarifying the
importance of a continuous reducing power supply in the defense against stressful stimuli.
This has been previously shown in mice lacking catalase, which develop obesity and a
prediabetic phenotype [52]. Rupérez et al. found catalase activity to be negatively corre-
lated with childhood obesity and insulin resistance [53]. As commented above, increased
baseline G6PDH or 6PGDH activities may lead to a rise in superoxide production via NOX.
Superoxide should be converted into H2O2 by the superoxide dismutase, but according to
our data, superoxide dismutase activity is similar between groups at baseline and remains
unchanged between obese groups along the curve, probably because of the deviation of
superoxide radicals to Fenton and Haber–Weiss reactions (Supplementary Figure S1). In-
deed, plasma ferritin levels were considerably increased in ObIR+ with respect to controls
and metabolically healthy obese children. Increased H2O2 concentrations, in turn, may
also affect catalase activity, since H2O2 has been shown to produce reversible inhibitions
and irreversible inactivation to bovine catalase [54,55]. Furthermore, S-Nitrosation has
been found to mediate catalase activity loss in gestational diabetes mellitus, postulating
that ROS/RNS-mediated post-translational modifications of antioxidant enzymes such as
catalase must be considered in metabolically unhealthy childhood obesity-related oxidative
stress [56]. Indeed, we have recently provided some evidence of catalase S-Nitrosation
in obese children [57]. The increase in superoxide and NO generates ONOO−, which
may also mediate the nitration of catalase and other enzymes in the erythrocyte, such as
hemoglobin, which can be a marker of nitro-oxidative stress [58,59].
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One limitation of our study is the relatively small group size which suggests our
results should be interpreted with caution. It would be desirable to scale-up the sample
size in the near future, including patients from different centers and different origins.
This highlights another limitation of our study, which is the use of classical (though well
validated), techniques to perform our measurements, requiring immediate and complex
processing of blood samples. This limits the possibility to receive samples from different
centers to be analyzed. Thus, it would be desirable to replicate these results with novel
methodological strategies to facilitate reproducibility and to perform multicenter studies.
5. Conclusions
Altogether, our data suggest that the availability of NADPH in compromised situations
of metabolic stress, induced by glucose intake, plays a pivotal role in the antioxidant
response of erythrocytes. We have found a relation between erythrocytes’ altered reducing
power supplies and the oxidative stress-mediated pathophysiology of insulin resistance in
prepubertal obese children. The inability of ObIR+ children’s erythrocytes to synthesize or
recycle NADPH due to blunted dehydrogenases activities leads to an altered redox status,
as shown by lowered GSH levels, since glutathione reductase lacks the reducing power
needed for this process. In this situation, many antioxidant enzymes may not fully exert
their functions to neutralize oxidizing species generated in the red blood cells by multiple
mechanisms. Excess reactive species lead to lipid and protein oxidation which, in turn,
may affect the integrity of the erythrocyte.
We found a physiological deviation of redox balance (oxidative eustress) in obese
children without insulin resistance, and a supraphysiological deviation (oxidative distress)
in the insulin-resistant group.
Supplementary Materials: The following are available online at https://www.mdpi.com/2076-392
1/10/2/244/s1, Figure S1: Glucose and glutathione metabolism in the erythrocyte.
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